£515.00

The 2023-2028 Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes in India

Price data last checked 73 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days · 1 data points (no recent data)

Historical
Generating forecast…
Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price
1 day 0 0 1 1 1 £515 Days at Price

Price Analysis

Most common price: £515 (1 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 1 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes in the United States
99% match

The 2023-2028 Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes in the United States

£520.00 30 Apr 2026
The 2023-2028 Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes for US Zip Codes
99% match

The 2023-2028 Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes for US Zip Codes

£490.00 02 Jul 2026
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India
98% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India

£515.00 24 Jun 2026
The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics
98% match

The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics

£795.00 27 Jun 2026
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China
98% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China

£495.00 11 Jul 2026
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in Japan
98% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in Japan

£495.00 24 Jun 2026
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics for US Zip Codes

£490.00 29 Jun 2026
The 2023-2028 Outlook for Immunoglobulin Diagnostic Tests in India
96% match

The 2023-2028 Outlook for Immunoglobulin Diagnostic Tests in India

£515.00 13 Apr 2026
The 2021-2026 World Outlook for Intravenous Immunoglobulin Technologies
96% match

The 2021-2026 World Outlook for Intravenous Immunoglobulin Technologies

£795.00 30 Apr 2026
The 2023-2028 Outlook for Immunoglobulin Plasma Therapeutics in the United States
95% match

The 2023-2028 Outlook for Immunoglobulin Plasma Therapeutics in the United States

£520.00 20 Apr 2026
The 2023-2028 Outlook for Myasthenia Gravis in India
95% match

The 2023-2028 Outlook for Myasthenia Gravis in India

£515.00 27 Jun 2026
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in India
95% match

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in India

£515.00 30 Jun 2026
The 2023-2028 Outlook for Intravenous Therapy and Vein Access in India
95% match

The 2023-2028 Outlook for Intravenous Therapy and Vein Access in India

£515.00 20 Jun 2026
The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States
95% match

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States

£520.00 01 Jul 2026
The 2023-2028 Outlook for Intravenous Therapy and Vein Access in the United States
95% match

The 2023-2028 Outlook for Intravenous Therapy and Vein Access in the United States

£520.00 20 Jun 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
95% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States

£520.00 12 Jun 2026
The 2023-2028 Outlook for Cable Tvs in India
95% match

The 2023-2028 Outlook for Cable Tvs in India

£515.00 12 Apr 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
95% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

£515.00 17 Jun 2026
The 2023-2028 Outlook for In-Game Advertising for PC-Based Online Games in India
95% match

The 2023-2028 Outlook for In-Game Advertising for PC-Based Online Games in India

£515.00 23 Jun 2026
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States
95% match

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States

£520.00 20 Jun 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
95% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

£515.00 13 Jun 2026
The 2023-2028 Outlook for Gamified Healthcare Solutions in the United States
95% match

The 2023-2028 Outlook for Gamified Healthcare Solutions in the United States

£520.00 22 Jun 2026
The 2013-2018 Outlook for Lou Gehrig's Disease Drugs in India
95% match

The 2013-2018 Outlook for Lou Gehrig's Disease Drugs in India

£495.00 20 Jun 2026
The 2021-2026 World Outlook for Interventional Neurology
95% match

The 2021-2026 World Outlook for Interventional Neurology

£795.00 07 May 2026